Literature DB >> 11895552

Mediation of transcatheter arterial chemoembolization induced gastric slow-wave dysrhythmia by endogenous prostaglandin.

Chi-Sen Chang1, Sheng-Sun Yang, Hong-Zen Yeh, Chung-Wang Ko, Han-Chung Lien, Gran-Hum Chen.   

Abstract

BACKGROUND AND AIMS: In recent years, gastric slow-wave dysrhythmias induced by transcatheter arterial chemoembolization (TACE) have been observed. Enhanced endogenous prostaglandin may be a possible mechanism for the myoelectrical changes. The aim of this study was to evaluate whether the gastric slow-wave dysrhythmias induced by TACE may be mediated by ketoprofen, a prostaglandin synthesis inhibitor.
METHODS: Twenty-three patients with hepatocellular carcinoma (HCC) admitted for TACE were enrolled. A follow-up TACE was scheduled to take place 2 months later. During the next admission for TACE, 50 mg of ketoprofen was given intramuscularly 12 h for 3 days, beginning 48 h before TACE, as premedication. Cutaneous electrogastrography (EGG) was performed before and within 24 h after TACE.
RESULTS: The results showed that the change in the fasting EGG parameters after TACE without premedication was not statistically significant. However, the postprandial EGG parameters, including the dominant frequency (DF); the percentages of DF in the normal, bradygastric and tachygastric range; along with the dominant frequency instability coefficient, deteriorated significantly after the procedure (P < 0.01). After the follow-up TACE with ketoprofen premedication, neither the fasting nor postprandial EGG parameters in the control group changed significantly.
CONCLUSIONS: Gastric slow-wave dysrhythmias induced by TACE may be mediated by ketoprofen, a prostaglandin synthesis inhibitor, in HCC patients. However, the improvement in the gastric myoelectrical activity does not eliminate the degree of nausea/vomiting after TACE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895552     DOI: 10.1046/j.1440-1746.2002.02659.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  2 in total

1.  Percutaneous local therapies for hepatocellular carcinoma impair gastric function.

Authors:  Fumihiko Kinekawa; Kazuya Matsuda; Tsutomu Masaki; Kazutaka Kurokohchi; Hirohito Yoneyama; Hideyuki Inoue; Hirohide Kurata; Yoshihito Uchida; Seishiro Watanabe; Shigeki Kuriyama
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

2.  Influence of percutaneous local therapy for hepatocellular carcinoma on gastric function.

Authors:  Mitsuyoshi Kobayashi; Fumihiko Kinekawa; Kazuya Matsuda; Shintaro Fujihara; Noriko Nishiyama; Takako Nomura; Joji Tani; Hisaaki Miyoshi; Hideki Kobara; Akihiro Deguchi; Hirohito Yoneyama; Hirohito Mori; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.